HLNCF
Price
$4.90
Change
+$0.06 (+1.24%)
Updated
Sep 4 closing price
Capitalization
44.18B
SGIOF
Price
$19.00
Change
+$1.04 (+5.79%)
Updated
Sep 3 closing price
Capitalization
15.32B
Interact to see
Advertisement

HLNCF vs SGIOF

Header iconHLNCF vs SGIOF Comparison
Open Charts HLNCF vs SGIOFBanner chart's image
HALEON
Price$4.90
Change+$0.06 (+1.24%)
Volume$2.81K
Capitalization44.18B
Shionogi & Co
Price$19.00
Change+$1.04 (+5.79%)
Volume$101
Capitalization15.32B
HLNCF vs SGIOF Comparison Chart in %
Loading...
HLNCF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SGIOF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
HLNCF vs. SGIOF commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HLNCF is a Buy and SGIOF is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (HLNCF: $4.90 vs. SGIOF: $19.00)
Brand notoriety: HLNCF and SGIOF are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: HLNCF: 18% vs. SGIOF: 15%
Market capitalization -- HLNCF: $44.18B vs. SGIOF: $15.32B
HLNCF [@Pharmaceuticals: Generic] is valued at $44.18B. SGIOF’s [@Pharmaceuticals: Generic] market capitalization is $15.32B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $67.95B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.88B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HLNCF’s FA Score shows that 1 FA rating(s) are green whileSGIOF’s FA Score has 2 green FA rating(s).

  • HLNCF’s FA Score: 1 green, 4 red.
  • SGIOF’s FA Score: 2 green, 3 red.
According to our system of comparison, SGIOF is a better buy in the long-term than HLNCF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HLNCF’s TA Score shows that 6 TA indicator(s) are bullish while SGIOF’s TA Score has 4 bullish TA indicator(s).

  • HLNCF’s TA Score: 6 bullish, 3 bearish.
  • SGIOF’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, HLNCF is a better buy in the short-term than SGIOF.

Price Growth

HLNCF (@Pharmaceuticals: Generic) experienced а +0.82% price change this week, while SGIOF (@Pharmaceuticals: Generic) price change was +5.79% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -0.80%. For the same industry, the average monthly price growth was +10.24%, and the average quarterly price growth was +86.08%.

Industries' Descriptions

@Pharmaceuticals: Generic (-0.80% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HLNCF($44.2B) has a higher market cap than SGIOF($15.3B). HLNCF has higher P/E ratio than SGIOF: HLNCF (21.70) vs SGIOF (14.04). SGIOF YTD gains are higher at: 55.610 vs. HLNCF (4.701). SGIOF has higher annual earnings (EBITDA): 206B vs. HLNCF (2.71B). SGIOF has more cash in the bank: 576B vs. HLNCF (676M). HLNCF has less debt than SGIOF: HLNCF (8.45B) vs SGIOF (11.7B). SGIOF has higher revenues than HLNCF: SGIOF (419B) vs HLNCF (11B).
HLNCFSGIOFHLNCF / SGIOF
Capitalization44.2B15.3B289%
EBITDA2.71B206B1%
Gain YTD4.70155.6108%
P/E Ratio21.7014.04155%
Revenue11B419B3%
Total Cash676M576B0%
Total Debt8.45B11.7B72%
FUNDAMENTALS RATINGS
SGIOF: Fundamental Ratings
SGIOF
OUTLOOK RATING
1..100
37
VALUATION
overvalued / fair valued / undervalued
1..100
24
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
2
PRICE GROWTH RATING
1..100
42
P/E GROWTH RATING
1..100
38
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
HLNCFSGIOF
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
57%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
70%
Bearish Trend 2 days ago
60%
Momentum
ODDS (%)
Bullish Trend 2 days ago
68%
Bullish Trend 2 days ago
48%
MACD
ODDS (%)
Bullish Trend 2 days ago
68%
Bullish Trend 2 days ago
53%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
63%
Bullish Trend 2 days ago
44%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
65%
Bullish Trend 2 days ago
51%
Advances
ODDS (%)
Bullish Trend 8 days ago
70%
N/A
Declines
ODDS (%)
Bearish Trend 3 days ago
58%
N/A
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
43%
Aroon
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
39%
View a ticker or compare two or three
Interact to see
Advertisement
HLNCF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SGIOF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BMRC24.860.72
+2.98%
Bank of Marin Bancorp
REXR42.081.11
+2.71%
Rexford Industrial Realty
PVL2.020.05
+2.54%
Permianville Royalty Trust
PRCH17.950.12
+0.67%
Porch Group
VIASP26.160.11
+0.43%
Via Renewables

HLNCF and

Correlation & Price change

A.I.dvisor indicates that over the last year, HLNCF has been loosely correlated with HLN. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if HLNCF jumps, then HLN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HLNCF
1D Price
Change %
HLNCF100%
+1.29%
HLN - HLNCF
49%
Loosely correlated
-0.51%
SGIOF - HLNCF
21%
Poorly correlated
N/A
STEK - HLNCF
11%
Poorly correlated
N/A
EAPIF - HLNCF
11%
Poorly correlated
N/A
ZTS - HLNCF
10%
Poorly correlated
+0.51%
More

SGIOF and

Correlation & Price change

A.I.dvisor tells us that SGIOF and AGYTF have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SGIOF and AGYTF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SGIOF
1D Price
Change %
SGIOF100%
N/A
AGYTF - SGIOF
25%
Poorly correlated
N/A
HLNCF - SGIOF
21%
Poorly correlated
+1.29%
SFOSF - SGIOF
11%
Poorly correlated
+0.19%
ROMJF - SGIOF
8%
Poorly correlated
-3.04%
TEVJF - SGIOF
8%
Poorly correlated
N/A
More